Acute tumor lysis syndrome after rituximab administration in Burkitt's lymphoma

Internal and Emergency Medicine

Volumn 3, Issue 2, 2008, Pages 161-163

  Otrock, Zaher K ^a   Hatoum, Hassan A ^a   Salem, Ziad M ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; RITUXIMAB;

ACUTE DISEASE; ARTICLE; BURKITT LYMPHOMA; CASE REPORT; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; TUMOR LYSIS SYNDROME;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TUMOR LYSIS SYNDROME;

EID: 43749083951     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-008-0099-1     Document Type: Article

References (15)

1. Maloney DG, Smith B, Rose A (2002) Rituximab: mechanism of action and resistance. Semin Oncol 29 (1 Suppl 2):2-9
2. Bienvenu J, Chvetzoff R, Salles G, et al (2001) Groupe d'Etude des Lymphomes de l'Adulte. Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment. Hematol J 2:378-384
3. Scott SD (1998) Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin's lymphoma. Cancer Pract 6:195-197
4. Yang H, Rosove MH, Figlin RA (1999) Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Am J Hematol 62:247-250
5. Jensen M, Winkler U, Manzke O, Diehl V, Engert A (1998) Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab). Ann Hematol 77:89-91
6. Abou Mourad Y, Taher A, Shamseddine A (2003) Acute tumor lysis syndrome in large B-cell non-Hodgkin lymphoma induced by steroids and anti-CD 20. Hematol J 4:222-224
7. Jabr FI (2005) Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma. Int J Hematol 82:312-314
8. Chasty RC, Liu-Yin JA (1993) Acute tumour lysis syndrome. Br J Hosp Med 49:488-492
9. Lerza R, Botta M, Barsotti B, et al (2002) Dexamethazone-induced acute tumor lysis syndrome in a T-cell malignant lymphoma. Leuk Lymphoma 43:1129-1132
10. Coutinho AK, de O Santos M, Pinczowski H, Feher O, del Giglio A (1997) Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids. Am J Hematol 54:85-86
11. Malik IA, Abubakar S, Alam F, Khan A (1994) Dexamethasone-induced tumor lysis syndrome in high-grade non-Hodgkin's lymphoma. South Med J 87:409-411
12. Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ (2004) Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 116:546-554
13. Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127:3-11
14. Jasek AM, Day HJ (1994) Acute spontaneous tumor lysis syndrome. Am J Hematol 47:129-131
15. Lin TS, Lucas MS, Byrd JC (2003) Rituximab in B-cell chronic lymphocytic leukemia. Semin Oncol 30:483-492